These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 35715860)

  • 61. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.
    Sami E; Paul BT; Koziol JA; ElShamy WM
    Cancer Res; 2020 Mar; 80(5):1102-1117. PubMed ID: 31911557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pomegranate peel extract inhibits expression of β-catenin, epithelial mesenchymal transition, and metastasis in triple negative breast cancer cells.
    Bagheri M; Fazli M; Saeednia S; Kor A; Ahmadiankia N
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):86-91. PubMed ID: 29974851
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
    Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
    Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
    Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
    Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis.
    Li X; Chen M; Lu W; Tang J; Deng L; Wen Q; Huang M; Deng R; Ye G; Ye W; Zhang D
    Cancer Lett; 2021 Apr; 503():32-42. PubMed ID: 33482262
    [TBL] [Abstract][Full Text] [Related]  

  • 67. AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
    Vitaliti A; Roccatani I; Iorio E; Perta N; Gismondi A; Chirico M; Pisanu ME; Di Marino D; Canini A; De Luca A; Rossi L
    Cell Oncol (Dordr); 2023 Feb; 46(1):93-115. PubMed ID: 36454513
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
    Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
    Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis.
    Chen Z; Lu P; Li M; Zhang Q; He T; Gan L
    Medicine (Baltimore); 2024 Feb; 103(8):e37264. PubMed ID: 38394486
    [TBL] [Abstract][Full Text] [Related]  

  • 70. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 71. M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis.
    Chen W; Chen M; Hong L; Xiahenazi A; Huang M; Tang N; Yang X; She F; Chen Y
    Exp Hematol Oncol; 2024 Aug; 13(1):83. PubMed ID: 39138521
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
    Pe KCS; Saetung R; Yodsurang V; Chaotham C; Suppipat K; Chanvorachote P; Tawinwung S
    PLoS One; 2022; 17(8):e0273044. PubMed ID: 35960749
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
    Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
    Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brazilein inhibits epithelial-mesenchymal transition (EMT) and programmed death ligand 1 (PD-L1) expression in breast cancer cells.
    Wudtiwai B; Kodchakorn K; Shwe TH; Pothacharoen P; Phitak T; Suninthaboonrana R; Kongtawelert P
    Int Immunopharmacol; 2023 May; 118():109988. PubMed ID: 36933493
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
    Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C
    Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.
    Wang L; Zhang L; Zhao L; Shao S; Ning Q; Jing X; Zhang Y; Zhao F; Liu X; Gu S; Zhao X; Luo M
    Int J Biol Sci; 2024; 20(2):446-463. PubMed ID: 38169627
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
    Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
    Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
    Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
    Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HMGB1 Positive Feedback Loop Between Cancer Cells and Tumor-Associated Macrophages Promotes Osteosarcoma Migration and Invasion.
    Hou C; Lu M; Lei Z; Dai S; Chen W; Du S; Jin Q; Zhou Z; Li H
    Lab Invest; 2023 May; 103(5):100054. PubMed ID: 36801636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.